Protalix BioTherapeutics
PLX
#8875
Rank
HK$1.75 B
Marketcap
HK$21.82
Share price
0.00%
Change (1 day)
14.47%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): HK$0.19 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$80.61 Million. In 2025 the company made an earning of -HK$33.4 Million a decrease over its 2024 earnings that were of HK$40.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.19 B-680.43%
2025 -HK$33.4 Million-181.6%
2024 HK$40.93 M-55.62%
2023 HK$92.23 M-199.05%
2022 -HK$93.13 Million-40.38%
2021 -HK$0.16 Billion-732.31%
2020 HK$24.7 M-130.53%
2019 -HK$80.91 Million189.85%
2018 -HK$27.92 Million-95.29%
2017 -HK$0.6 Billion308.12%
2016 -HK$0.15 Billion-32.37%
2015 -HK$0.22 Billion10.11%
2014 -HK$0.2 Billion-7.59%
2013 -HK$0.22 Billion
2011 -HK$0.25 Billion-19.39%
2010 -HK$0.31 Billion20.87%
2009 -HK$0.26 Billion32.26%
2008 -HK$0.19 Billion-5.46%
2007 -HK$0.21 Billion
2004 -HK$1.3 Million12.35%
2003 -HK$1.16 Million-11.1%
2002 -HK$1.31 Million-57.03%
2001 -HK$3.03 Million1.03%
2000 -HK$3 Million-53.22%
1999 -HK$6.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.20 B 27,847.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$6.42 B 3,211.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$1.49 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$12.59 B 6,394.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel